Patents by Inventor Adrian Zürcher

Adrian Zürcher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD89 ACTIVATION IN THERAPY
    Publication number: 20170166640
    Abstract: The invention relates to the use of CD89 activating molecules, in particular Fc alpha comprising molecules, and more particularly, IgA, for inducing apoptosis in neutrophils. Anti-CD89 antibodies can alternatively be used. The CD89 activation is beneficial in the treatment of various disorders associated with increases in neutrophils, such as autoimmune disorders, inflammatory disorders, NETosis, or cystic fibrosis.
    Type: Application
    Filed: December 19, 2016
    Publication date: June 15, 2017
    Applicants: CSL BEHRING AG, UNIVERSITÄT BERN
    Inventors: Stephan VON GUNTEN, Marc WEHRLI, Adrian ZÜRCHER, Sylvia MIESCHER
  • CD89 activation in therapy
    Patent number: 9522184
    Abstract: The invention relates to the use of CD89 activating molecules, in particular Fc alpha comprising molecules, and more particularly, IgA, for inducing apoptosis in neutrophils. Anti-CD89 antibodies can alternatively be used. The CD89 activation is beneficial in the treatment of various disorders associated with increases in neutrophils, such as autoimmune disorders, inflammatory disorders, NETosis, or cystic fibrosis.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: December 20, 2016
    Assignees: CSL BEHRING AG, UNIVERSITAT BERN
    Inventors: Stephan Von Gunten, Marc Wehrli, Adrian Zürcher, Sylvia Miescher
  • COMPOSITIONS COMPRISING SECRETORY - LIKE IMUNOGLOBULINS
    Publication number: 20150056180
    Abstract: The invention relates to methods for preparing compositions comprising secretory-like immunoglobulin, in particular secretory-like IgA and/or secretory-like IgM, and compositions obtainable by the methods.
    Type: Application
    Filed: March 8, 2013
    Publication date: February 26, 2015
    Inventors: Blaise Corthésy, Stéphanie Longet, Marius Lötscher, Sylvia Miescher, Adrian Zürcher
  • TREATMENT OF MUCOSITIS WITH IMMUNOGLOBULIN
    Publication number: 20150030613
    Abstract: The invention relates to compositions comprising immunoglobulin for use in the treatment of mucositis by topical application. In particular, the invention relates to compositions comprising J chain-containing IgA and secretory component for the treatment of mucositis.
    Type: Application
    Filed: March 8, 2013
    Publication date: January 29, 2015
    Inventors: Christoph Aebi, Sonja Christina Lueer, Alexander Schaub, Sylvia Miescher, Adrian Zürcher, Cédric Pierre Vonarburg
  • CD89 ACTIVATION IN THERAPY
    Publication number: 20130302345
    Abstract: The invention relates to the use of CD89 activating molecules, in particular Fc alpha comprising molecules, and more particularly, IgA, for inducing apoptosis in neutrophils. Anti-CD89 antibodies can alternatively be used. The CD89 activation is beneficial in the treatment of various disorders associated with increases in neutrophils, such as autoimmune disorders, inflammatory disorders, NETosis, or cystic fibrosis.
    Type: Application
    Filed: December 14, 2011
    Publication date: November 14, 2013
    Applicants: UNIVERSITÄT BERN, CSL BEHRING AG
    Inventors: Stephan Von Gunten, Marc Wehrli, Adrian Zürcher, Sylvia Miescher